framycetin has been researched along with Chronic Disease in 84 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 52 (61.90) | 18.7374 |
1990's | 15 (17.86) | 18.2507 |
2000's | 12 (14.29) | 29.6817 |
2010's | 3 (3.57) | 24.3611 |
2020's | 2 (2.38) | 2.80 |
Authors | Studies |
---|---|
Gadil, E; Leach, A; Morris, P; Stubbs, E; Wood, Y | 1 |
Dat, AD; Doust, J; Pham, KB; Poon, F | 1 |
Kent, SE; Lancaster, J; Mathews, J; Thussey, C; Williams, RS | 1 |
Couzos, S; Culbong, M; Lea, T; Mueller, R; Murray, R | 1 |
Buczkowska-Radlińska, J; Giedrys-Kalemba, S; Trusewicz, M | 1 |
Bruintjes, TD; Huizing, EH; Van Ginkel, CJ | 1 |
Brändle, P; Linder, TE; Zwicky, S | 1 |
Dilu, NJ; Giyulu, N | 1 |
Krämer, D; Kunze, H | 1 |
Cheng, NS; Hu, HJ; Li, FY; Ma, WJ; Shi, YJ; Wang, JK; Wu, ZR; Yang, Q | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Auffarth, GU; Kretz, FT; Mackensen, F | 1 |
Arrúa, M; Carpinelli, L; Cibils, D; Fariña, N; Laspina, F; Mino de Kaspar, H; Samudio, M; Sanabria, R | 1 |
Deitmer, T | 1 |
AVANT, WH; SMITH, CA | 1 |
SPENCER, MC | 1 |
Levine, N | 1 |
Muyunga, CK; Nyembue, DT; Sabue, MJ; Tshiswaka, JM | 1 |
Lund, VJ; Ragab, SM; Saleh, HA; Scadding, G | 1 |
Fayad, JN; Wilkinson, EP | 1 |
Lundskog, B; Nylander, E; Wahlin, A; Wahlin, YB | 1 |
Bayon, R; Goyal, S; Hotaling, J; Izzo, AD; Otting, M; Richter, CP; Suh, E; Walsh, JT | 1 |
Phillips, A | 1 |
Fujita, K; Takimoto, I | 1 |
Hattori, N; Hirayama, C; Ichida, F; Koizumi, T; Kosaka, Y; Ooya, T; Sato, S; Shimada, Y; Takahashi, Y; Takeda, H; Takino, T; Wakui, K; Yoshiba, A | 1 |
Crossley, IR; Williams, R | 1 |
Gydé, MC; Kavalec, EC; Norris, D | 1 |
Garcia Ramos, G; Márquez, MA; Ramos, C; Ramos-Uribe, MH; Uribe, M; Vargas, F; Villalobos, A | 1 |
Escobedo, V; García-Ramos, G; Guevara, L; Lisker, R; Márquez, MA; Murillo, H; Uribe, M | 1 |
Campodónico Garibaldi, I; Escudero, P; Guerrero, B | 1 |
Anver, MR; Battles, JK; Blumenauer, LL; Gonda, MA; Gorelick, PL; Haines, DC; Russell, RJ; Ward, JM | 1 |
England, J; Jones, AS; Wilde, AD | 1 |
Chien, MC; Fagiuoli, S; Gavaler, JS; Van Thiel, DH; Wright, HI | 1 |
Sherertz, EF | 1 |
Tong, MC; van Hasselt, CA; Woo, JK | 1 |
Browning, GG; Connolly, AA; Picozzi, GL | 1 |
Alper, CM; Bluestone, CD; Casselbrant, ML; Dohar, JE; Doyle, WJ; Kenna, MA; Rose, EA | 1 |
Hazen, KC; Howell, SA; Theisz, GW | 1 |
Miró, N | 1 |
Conn, HO; Leevy, CM; Levy, LL; Maddrey, WC; Rodgers, JB; Seeff, L; Vlahcevic, ZR | 1 |
Baxter, JD | 1 |
Baxter, JD; Carson, R; Katsarkas, A; Ling, D | 1 |
Glouberman, S | 1 |
Iunda, IF; Kushniruk, IuI | 1 |
Calzetti, C; Fiaccadori, F; Missale, G; Pedretti, G | 1 |
Alessandrini, F; Bassi, R; Mariani, R; Tardio, M | 1 |
Ramadan, HH; Tarazi, T; Zaytoun, GM | 1 |
Allen, WE; Boyd, EH | 1 |
Ben David, J; Fradis, M; Podoshin, L | 1 |
Chan, KL; Cole, PJ; Mackay, IS; Sykes, DA; Wilson, R | 2 |
Baudoin, C; Cuenant, G; Guerrier, Y; Plante-Longchamp, G; Stipon, JP | 1 |
Nedoseko, GF; Russkiĭ, LI; Vladimirov, VV | 1 |
Fischer, JE | 1 |
Spitzy, KH | 1 |
Heinemann, M | 1 |
Cade, G; Lew-Sang, E; Macgibbon, CB; Shankly, KH; Shulman, A; Stahle, IO; Wright, RD | 1 |
Pannone, T | 1 |
Bernstein, MZ | 1 |
Devos, J; Guffens, JM; Pirotte, J | 1 |
Wegener, A | 1 |
Candlin, FT | 1 |
Bell, B; Jacobson, S | 1 |
Volodkevich, SM | 1 |
Paquet, KJ | 1 |
Czuba, M; Evans, WE; Greenberger, NJ; Kakos, GS; Spiegel, J | 1 |
Boonstra, S; Gips, CH; Qué, GS; Van Der Zwan, JC | 1 |
Conn, HO; Elkington, SG; Floch, MH | 1 |
Banwell, JG; Chatterjee, BD; Gorbach, SL; Jacobs, B; Mazumder, DN; Mitra, R; Sen, NN | 1 |
Kilachitskaia, VI; Skurkovich, GV; Tolkacheva, LI; Vasina, TA | 1 |
Genchikov, LA; Sokolovskiĭ, VT | 1 |
Bauer, KM | 1 |
Izumi, AK; Shmunes, E; Wood, MG | 1 |
Fung, WP; Khoo, OT | 1 |
Bircher, J; Haemmerli, UP; Hoffmann, K; Scollo-Lavizzari, G | 2 |
Lazarevska, B | 1 |
Anikina, TP; Buniatova, IM; Golosova, TV | 1 |
Easty, D; Garner, A; Jones, BR; Rice, NS; Tripathi, R | 1 |
Gavriliuk, IA; Gavriliuk, NA | 1 |
Cooper, DL | 1 |
Gahr, W | 1 |
Blackburn, CR; Ma, MH; McLeod, JG | 1 |
9 review(s) available for framycetin and Chronic Disease
Article | Year |
---|---|
Aloe vera for treating acute and chronic wounds.
Topics: Acute Disease; Aloe; Anti-Infective Agents, Local; Bandages; Biopsy; Burns; Chronic Disease; Framycetin; Gels; Hemorrhoids; Humans; Phytotherapy; Pressure Ulcer; Randomized Controlled Trials as Topic; Silver Sulfadiazine; Skin; Time Factors; Wound Healing; Wounds and Injuries | 2012 |
Ototoxicity of ear drops: a clinical perspective.
Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Chronic Disease; Drug Combinations; Framycetin; Hearing Loss, Sensorineural; Hearing Tests; Humans; Hydrocortisone; Male; Neomycin; Otitis Media; Polymyxin B; Solutions | 1995 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Topical and systemic treatment for chronic suppurative otitis media.
Topics: Administration, Oral; Administration, Topical; Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Male; Neomycin; Otitis Media, Suppurative; Polymyxins; Prognosis; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Treatment Outcome | 2002 |
Progress in the treatment of chronic portasystemic encephalopathy.
Topics: Amino Acids, Branched-Chain; Ammonia; Animals; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Colon; Dietary Proteins; Dogs; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Keto Acids; Lactulose; Levodopa; Metronidazole; Neomycin | 1984 |
Chronic finger dermatitis after trauma. Diagnosis: posttraumatic eczema with allergic contact dermatitis to neomycin, bacitracin, and topical corticosteroids.
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Bacitracin; Chronic Disease; Dermatitis, Allergic Contact; Eczema; Finger Injuries; Fingers; Hand Dermatoses; Humans; Male; Neomycin | 1996 |
Hepatic coma in cirrhosis, portal hypertension, and following portacaval shunt. Its etiologies and the current status of its treatment.
Topics: Acute Disease; Amino Acids; Ammonia; Brain; Chronic Disease; Colon; Dietary Proteins; Fatty Acids; Glutamine; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Neomycin; Neurotransmitter Agents; Portacaval Shunt, Surgical; Postoperative Complications; Sterilization; Urease | 1974 |
[The use of antibiotics in otologic practice].
Topics: Acute Disease; Anti-Bacterial Agents; Bacitracin; Bronchitis; Chloramphenicol; Chronic Disease; Ear Diseases; Humans; Labyrinth Diseases; Laryngitis; Neomycin; Novobiocin; Otitis Externa; Otitis Media; Penicillins; Pneumococcal Infections; Polymyxins; Respiratory Tract Infections; Staphylococcal Infections; Streptococcal Infections; Streptomycin; Tetracycline; Tonsillitis; Tracheal Diseases | 1969 |
Recognition and management of acute and chronic hepatic encephalopathy.
Topics: Acute Disease; Amines; Ammonia; Animals; Brain Edema; Central Nervous System; Chronic Disease; Diet Therapy; Dihydroxyphenylalanine; Exchange Transfusion, Whole Blood; Fatty Acids, Volatile; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neomycin; Renal Dialysis | 1973 |
22 trial(s) available for framycetin and Chronic Disease
Article | Year |
---|---|
Topical ciprofloxin versus topical framycetin-gramicidin-dexamethasone in Australian aboriginal children with recently treated chronic suppurative otitis media: a randomized controlled trial.
Topics: Administration, Topical; Adolescent; Anti-Bacterial Agents; Anti-Inflammatory Agents; Australia; Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Dexamethasone; Drug Therapy, Combination; Female; Framycetin; Gramicidin; Humans; Infant; Male; Native Hawaiian or Other Pacific Islander; Otitis Media, Suppurative; Treatment Outcome | 2008 |
Effectiveness of ototopical antibiotics for chronic suppurative otitis media in Aboriginal children: a community-based, multicentre, double-blind randomised controlled trial.
Topics: Administration, Topical; Adolescent; Anti-Infective Agents; Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Community Health Services; Dexamethasone; Drug Administration Schedule; Female; Framycetin; Gramicidin; Humans; Infant; Male; Native Hawaiian or Other Pacific Islander; Otitis Media, Suppurative; Povidone-Iodine; Queensland; Treatment Outcome; Western Australia | 2003 |
[Local antibiotic and enzymatic therapy of chronic osteomyelitis].
Topics: Adolescent; Adult; Child; Chronic Disease; Drug Synergism; Female; Framycetin; Humans; Male; Middle Aged; Osteomyelitis; Radiography; Trypsin | 1969 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Comparative study of the efficacy of different treatment options in patients with chronic blepharitis.
Topics: Administration, Ophthalmic; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Blepharitis; Chronic Disease; Dexamethasone; Eyelashes; Female; Gels; Hair Preparations; Humans; Male; Metronidazole; Middle Aged; Mite Infestations; Mites; Neomycin; Ointments; Pneumococcal Infections; Polymyxins; Severity of Illness Index; Staphylococcal Infections; Therapeutic Irrigation; Treatment Outcome; Young Adult | 2015 |
Nasal nitric oxide in objective evaluation of chronic rhinosinusitis therapy.
Topics: Administration, Intranasal; Adult; Aerosols; Chronic Disease; Dexamethasone; Double-Blind Method; Drug Combinations; Female; Glucocorticoids; Humans; Imidazoles; Male; Nasal Cavity; Nasal Polyps; Neomycin; Nitric Oxide; Rhinitis; Sinusitis; Treatment Failure | 2006 |
A controlled clinical trial of nicotinohydroxamic acid and neomycin in advanced chronic liver disease.
Topics: Ammonia; Chronic Disease; Clinical Trials as Topic; Electroencephalography; Female; Humans; Liver Diseases; Male; Middle Aged; Neomycin; Niacinamide | 1982 |
Progress in the treatment of chronic portasystemic encephalopathy.
Topics: Amino Acids, Branched-Chain; Ammonia; Animals; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Colon; Dietary Proteins; Dogs; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Keto Acids; Lactulose; Levodopa; Metronidazole; Neomycin | 1984 |
The weeping ear: clinical re-evaluation of treatment.
Topics: Adult; Bacterial Infections; Chronic Disease; Clinical Trials as Topic; Colistin; Double-Blind Method; Gentamicins; Hearing; Humans; Hydrocortisone; Neomycin; Otitis; Otitis Externa; Otitis Media; Tympanoplasty | 1982 |
Treatment of chronic portal--systemic encephalopathy with vegetable and animal protein diets. A controlled crossover study.
Topics: Adult; Ammonia; Animals; Chronic Disease; Clinical Trials as Topic; Diabetes Complications; Dietary Proteins; Electrocardiography; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Magnesium Hydroxide; Male; Meat; Middle Aged; Neomycin; Plant Proteins, Dietary | 1982 |
Treatment of chronic portal-systemic encephalopathy with lactose in lactase-deficient patients.
Topics: Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatic Encephalopathy; Humans; Lactose; Lactose Intolerance; Liver Cirrhosis; Magnesium Hydroxide; Male; Neomycin | 1980 |
An alternative to regular dressings for otitis externa and chronic supperative otitis media?
Topics: Administration, Topical; Chronic Disease; Drug Administration Schedule; Drug Combinations; Gramicidin; Humans; Neomycin; Nystatin; Ointments; Otitis; Otitis Externa; Otitis Media, Suppurative; Triamcinolone Acetonide | 1995 |
A double-blind comparative study of ofloxacin otic drops versus neomycin-polymyxin B-hydrocortisone otic drops in the medical treatment of chronic suppurative otitis media.
Topics: Anti-Infective Agents; Chronic Disease; Double-Blind Method; Drug Combinations; Humans; Hydrocortisone; Instillation, Drug; Neomycin; Ofloxacin; Otitis Media, Suppurative; Polymyxin B; Staphylococcal Infections | 1996 |
Randomized trial of neomycin/dexamethasone spray vs drop preparation for the treatment of active chronic mucosal otitis media.
Topics: Administration, Topical; Anti-Bacterial Agents; Chronic Disease; Dexamethasone; Drug Combinations; Female; Humans; Male; Middle Aged; Neomycin; Otitis Media, Suppurative; Solutions | 1997 |
Controlled multicenter study on chronic suppurative otitis media treated with topical applications of ciprofloxacin 0.2% solution in single-dose containers or combination of polymyxin B, neomycin, and hydrocortisone suspension.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Drug Combinations; Female; Humans; Hydrocortisone; Male; Microbial Sensitivity Tests; Middle Aged; Neomycin; Otitis Media, Suppurative; Polymyxin B; Prospective Studies; Treatment Outcome | 2000 |
Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
Topics: Aged; Ammonia; Blood; Chronic Disease; Clinical Trials as Topic; Disaccharides; Electroencephalography; Feces; Female; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactulose; Male; Mental Processes; Middle Aged; Neomycin; Prospective Studies; Sorbitol; Trail Making Test | 1977 |
Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial.
Topics: Aged; Ammonia; Chronic Disease; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Neomycin; Prospective Studies; Rifamycins; Rifaximin | 1991 |
Relative importance of antibiotic and improved clearance in topical treatment of chronic mucopurulent rhinosinusitis. A controlled study.
Topics: Administration, Intranasal; Adult; Aerosols; Aged; Chronic Disease; Cilia; Clinical Trials as Topic; Dexamethasone; Double-Blind Method; Drug Combinations; Female; Humans; Imidazoles; Male; Middle Aged; Mucus; Neomycin; Random Allocation; Respiratory System; Rhinitis; Sinusitis; Suppuration | 1986 |
Efficacy of endonasal neomycin-tixocortol pivalate irrigation in the treatment of chronic allergic and bacterial sinusitis.
Topics: Administration, Intranasal; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Bacterial Infections; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Male; Middle Aged; Neomycin; Random Allocation; Respiratory Hypersensitivity; Sinusitis; Therapeutic Irrigation | 1986 |
The treatment of dermatological infections with a manganese phenanthroline chelate. A controlled clinical trial.
Topics: Acetates; Arthrodermataceae; Bacitracin; Candida; Chronic Disease; Clinical Trials as Topic; Dermatomycoses; Drug Resistance, Microbial; Humans; Manganese; Nails; Neomycin; Phenanthrolines; Polymyxins; Quinolines; Salicylamides; Salicylates; Skin; Skin Diseases, Infectious; Sulfates | 1970 |
Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.
Topics: Adult; Aged; Alcoholism; Ammonia; Brain Diseases; Chronic Disease; Clinical Trials as Topic; Colon; Dietary Proteins; Disaccharides; Electroencephalography; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Intestines; Liver Cirrhosis; Male; Mental Disorders; Middle Aged; Neomycin; Neurologic Manifestations; Sorbitol | 1969 |
Local treatment with a corticosteroid-antibiotic preparation in infections of the ear.
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Child, Preschool; Chronic Disease; Clinical Trials as Topic; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Neomycin; Otitis Media; Placebos; Triamcinolone Acetonide | 1970 |
55 other study(ies) available for framycetin and Chronic Disease
Article | Year |
---|---|
Comparison of compliance between topical aural medications.
Topics: Administration, Topical; Chronic Disease; Dexamethasone; Drug Combinations; Framycetin; Gentamicins; Gramicidin; Humans; Hydrocortisone; Neomycin; Otitis Externa; Otitis Media, Suppurative; Patient Compliance; Statistics, Nonparametric | 2003 |
[The effectiveness of some methods in eliminating bacteria from the root canal of a tooth with chronic apical periodontitis].
Topics: Adolescent; Adult; Aged; Chronic Disease; Colony Count, Microbial; Female; Framycetin; Humans; Hydrocarbons, Iodinated; Male; Middle Aged; Periapical Periodontitis; Polymyxin B; Root Canal Therapy | 2005 |
Allergy due to topical medications in chronic otitis externa and chronic otitis media.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aminoglycosides; Chronic Disease; Dermatitis, Allergic Contact; Ear, Middle; Female; Framycetin; Humans; Male; Middle Aged; Neomycin; Otitis Media; Patch Tests | 1995 |
[Recurrent parotitis in children and HIV infection. Apropos of 4 cases].
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Chronic Disease; Contrast Media; Dental Prophylaxis; Diclofenac; Drug Therapy, Combination; Female; Framycetin; HIV Infections; Humans; Iodized Oil; Male; Parotitis; Radiography; Recurrence; Spiramycin | 1998 |
Biliary antibiotics irrigation for E. coli-induced chronic proliferative cholangitis and hepatolithiasis: A pathophysiological study in rabbits.
Topics: Animals; Anti-Bacterial Agents; Bacitracin; Chlorhexidine; Cholangitis; Chronic Disease; Collagen Type I; Cytokines; Drug Combinations; Escherichia coli; Escherichia coli Infections; Lipopolysaccharides; Lithiasis; Liver Diseases; Metronidazole; Neomycin; Nitrofurazone; Ofloxacin; Polymyxin B; Povidone-Iodine; Rabbits; Therapeutic Irrigation; Vascular Endothelial Growth Factor A | 2020 |
[Seclusio pupillae, cataracta complicata in chronic, recurrent panuveitis: combined surgery with synechiolyses, pupilloplastic, cataract surgery and intravitreal dexamethasone implants].
Topics: Adolescent; Anti-Inflammatory Agents; Cataract Extraction; Chorioretinitis; Chronic Disease; Combined Modality Therapy; Dexamethasone; Drug Implants; Drug Therapy, Combination; Humans; Male; Neomycin; Panuveitis; Polymyxins; Prednisolone; Pupil; Pupil Disorders; Recurrence; Tissue Adhesions; Vitreous Body | 2013 |
Neomycin perfusion for chronic osteomyelitis.
Topics: Chronic Disease; Fractures, Bone; Humans; Neomycin; Osteomyelitis | 1962 |
ENZYMATIC TREATMENT OF CHRONIC SKIN ULCERS.
Topics: Chronic Disease; Drug Therapy; Geriatrics; Humans; Neomycin; Ointments; Peptide Hydrolases; Skin Ulcer; Wound Healing | 1965 |
Chronic foot ulcer. Identifying patient's current topical therapy aids in diagnosis.
Topics: Administration, Topical; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacitracin; Chronic Disease; Dermatitis, Contact; Female; Foot Ulcer; Humans; Neomycin; Venous Insufficiency | 2003 |
Bacteriology of chronic suppurative otitis media in congolese children.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Chronic Disease; Citrobacter; Congo; Female; Humans; Infant; Male; Neomycin; Ofloxacin; Otitis Media, Suppurative; Proteus mirabilis; Pseudomonas aeruginosa; Salmonella | 2003 |
Allergic contact dermatitis of the auricle.
Topics: Adult; Anti-Bacterial Agents; Chronic Disease; Dermatitis, Allergic Contact; Ear Diseases; Ear, External; Humans; Intraoperative Care; Male; Neomycin; Otitis Media; Tympanoplasty | 2007 |
Genital graft-versus-host disease in a male following allogeneic stem cell transplantation.
Topics: Anti-Bacterial Agents; Betamethasone; Chronic Disease; Glucocorticoids; Graft vs Host Disease; Humans; Male; Middle Aged; Neomycin; Penile Diseases; Stem Cell Transplantation; Transplantation, Homologous | 2007 |
Optical stimulation of auditory neurons: effects of acute and chronic deafening.
Topics: Acute Disease; Animals; Chronic Disease; Cochlear Nerve; Deafness; Electric Stimulation; Evoked Potentials, Auditory, Brain Stem; Gerbillinae; Light; Models, Animal; Neomycin; Nerve Degeneration; Protein Synthesis Inhibitors; Spiral Ganglion | 2008 |
A simple treatment for chronic otitis externa.
Topics: Chronic Disease; Humans; Hydrocortisone; Neomycin; Otitis Externa | 1967 |
[Effect of intramaxillary injection of Predex in chronic sinusitis].
Topics: Chronic Disease; Humans; Neomycin; Prednisolone; Propionates; Sinusitis | 1967 |
[Trial of an anabolic-antibiotic combination in benign cervicopathies].
Topics: Adult; Chronic Disease; Drug Combinations; Electrocoagulation; Female; Humans; Middle Aged; Neomycin; Testosterone; Uterine Cervical Diseases | 1981 |
Use of antibiotics to prevent hepatitis and typhlitis in male scid mice spontaneously infected with Helicobacter hepaticus.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bismuth; Cecal Diseases; Cecum; Chronic Disease; Helicobacter; Helicobacter Infections; Hepatitis, Animal; Inflammation; Liver; Male; Metronidazole; Mice; Mice, SCID; Neomycin; Rodent Diseases; Tetracycline | 1995 |
Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment.
Topics: Adult; Ammonia; Chronic Disease; Dietary Proteins; Female; Gastric Emptying; Gastrointestinal Transit; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Neomycin | 1994 |
Treatment of chronic suppurative otitis media with topical ciprofloxacin.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Drug Combinations; Humans; Hydrocortisone; Macaca fascicularis; Neomycin; Otitis Media, Suppurative; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome | 1998 |
Chronic urinary tract infection due to Candida utilis.
Topics: Aged; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Humans; Instillation, Drug; Lung Diseases, Obstructive; Male; Neomycin; Prostatic Hyperplasia; Recurrence; Urinary Tract Infections | 1999 |
Chronic otitis media and hearing loss in the Eskimo population of Canada.
Topics: Acetates; Bacitracin; Canada; Chronic Disease; Drug Combinations; Ethanol; Fluocinolone Acetonide; Hearing Disorders; Humans; Inuit; Neomycin; Otitis Media; Polymyxins; Referral and Consultation; Tympanoplasty; Tyrothricin | 1977 |
The Nakasuk Project- the conservative treatment of chronic otitis media in Inuit elementary school children.
Topics: Acetates; Bacitracin; Canada; Child; Chronic Disease; Drug Combinations; Ear Canal; Ear, Middle; Education; Educational Measurement; Fluocinolone Acetonide; Hearing Aids; Hearing Disorders; Humans; Inuit; Neomycin; Otitis Media; Polymyxin B | 1979 |
Hepatic encephalopathy.
Topics: Chronic Disease; Hepatic Encephalopathy; Humans; Lactulose; Neomycin | 1977 |
[Functional state of the testis after the use of certain antibiotics and nitrofuran preparations].
Topics: Adult; Anti-Bacterial Agents; Chronic Disease; Depression, Chemical; Humans; Hydantoins; Male; Middle Aged; Neomycin; Nitrofurans; Nitrofurantoin; Prostatitis; Sperm Motility; Spermatogenesis; Spermatozoa; Streptomycin; Testis; Tetracycline; Time Factors; Urethritis | 1975 |
Allergic contact conjunctivitis without eyelid involvement.
Topics: Aged; Chronic Disease; Conjunctivitis, Allergic; Eyelid Diseases; Female; Humans; Neomycin; Ophthalmic Solutions; Patch Tests | 1991 |
Use of prophylactic otic drops after tympanostomy tube insertion.
Topics: Administration, Topical; Adolescent; Child; Child, Preschool; Chronic Disease; Drug Combinations; Female; Follow-Up Studies; Humans; Hydrocortisone; Infant; Male; Middle Ear Ventilation; Neomycin; Otitis Media with Effusion; Polymyxin B; Prospective Studies; Sulfonamides; Surgical Wound Infection | 1991 |
Delayed drainage of neomycin from the uterus of mares susceptible to endometritis.
Topics: Absorption; Animals; Chronic Disease; Endometritis; Female; Horse Diseases; Horses; Neomycin; Recurrence; Uterus | 1990 |
Ototoxicity of ear drops in patients suffering from chronic otitis media.
Topics: Adolescent; Adult; Child; Chronic Disease; Dexamethasone; Drug Combinations; Female; Hearing Loss, Sensorineural; Humans; Male; Neomycin; Otitis Media; Polymyxins | 1989 |
Effect of head position on the efficacy of topical treatment of chronic mucopurulent rhinosinusitis.
Topics: Administration, Intranasal; Adult; Aged; Betamethasone; Chronic Disease; Drug Combinations; Female; Head; Humans; Male; Middle Aged; Neomycin; Posture; Rhinitis; Sinusitis | 1987 |
[Use of kenakort and kenacomb in the therapy of certain dermatoses].
Topics: Acute Disease; Adolescent; Adult; Aged; Chronic Disease; Drug Combinations; Female; Gramicidin; Humans; Hypersensitivity; Male; Middle Aged; Neomycin; Nystatin; Ointments; Skin Diseases; Triamcinolone Acetonide | 1974 |
[On the treatment of chronic surgical infections].
Topics: Anti-Bacterial Agents; Bacteria; Chloramphenicol; Chronic Disease; Drug and Narcotic Control; Drug Antagonism; Drug Incompatibility; Erythromycin; Infections; Kanamycin; Long-Term Care; Neomycin; Novobiocin; Penicillins; Polymyxins; Streptomycin; Sulfonamides; Tetracycline | 1967 |
[Treatment of some inflammatory disorders of the ear with an association of fluocinolone acetonide, polymyxin B and neomycin].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Chronic Disease; Female; Fluocinolone Acetonide; Humans; Male; Middle Aged; Neomycin; Otitis; Otitis Media; Polymyxins | 1970 |
Chronic venous insufficiency. Discussion and case report of statis ulcer treatment.
Topics: Administration, Topical; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Blood; Chronic Disease; Drug Combinations; Gentamicins; Humans; Leg Ulcer; Male; Neomycin; Ointments; Polymyxins; Tyrothricin; Venous Insufficiency | 1974 |
Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
Topics: Ammonia; Blood Urea Nitrogen; Brain Diseases; Chlorides; Chronic Disease; Disaccharides; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactulose; Liver Cirrhosis; Liver Function Tests; Neomycin; Potassium; Sodium | 1974 |
[Evaluation of Uro-nebacetin form the viewpoint of the free-practicing urologist].
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Chronic Disease; Cystitis; Drug Combinations; Female; Humans; Male; Middle Aged; Neomycin; Sulfamethizole; Sulfates; Sulfathiazoles | 1974 |
Clinical trials with a new dermatologic solution.
Topics: Acute Disease; Animals; Anti-Infective Agents, Local; Chronic Disease; Dermatologic Agents; Dexamethasone; Dog Diseases; Dogs; Drug Combinations; Evaluation Studies as Topic; Female; Male; Neomycin; Otitis Externa; Pseudomonas Infections; Skin Diseases, Infectious; Thiabendazole | 1972 |
[The role of enzyme therapy in increasing the sanitizing effect of antibiotics in the treatment of chronic purulent otitis media with cholesteatoma].
Topics: Chloramphenicol; Cholesteatoma; Chronic Disease; Chymotrypsin; Deoxyribonucleases; Drug Therapy, Combination; Erythromycin Ethylsuccinate; Humans; Hyaluronoglucosaminidase; Neomycin; Otitis Media; Streptomycin; Trypsin | 1974 |
[Clinical aspects and therapy of acute and chronic liver insufficiency and hepatic failure].
Topics: Acid-Base Equilibrium; Acute Disease; Animals; Blood Donors; Chronic Disease; Diet Therapy; Exchange Transfusion, Whole Blood; Haplorhini; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Intestines; Liver Transplantation; Neomycin; Papio; Swine | 1972 |
Subtotal portacaval shunt obliteration for chronic hepatic encephalopathy.
Topics: Adult; Brain Diseases; Catheterization; Chronic Disease; Diet Therapy; Diet, Sodium-Restricted; Dietary Proteins; Female; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Liver Function Tests; Neomycin; Portacaval Shunt, Surgical; Portal Vein; Radiography; Tetracycline | 1973 |
Milk protein in the treatment of chronic portasystemic encephalopathy. A long-term study of therapeutic measures in a patient with chronic porta-systemic encephalopathy.
Topics: Aged; Ammonia; Animals; Chronic Disease; Diet Therapy; Dogs; Electroencephalography; Hepatic Encephalopathy; Humans; Lactose; Lactulose; Male; Milk Proteins; Neomycin; Portal System | 1974 |
Tropical sprue and malnutrition in West Bengal. I. Intestinal microflora and absorption.
Topics: Adult; Celiac Disease; Chronic Disease; Diet Therapy; Duodenum; Escherichia coli; Fats; Female; Folic Acid; Humans; Ileum; Intestinal Absorption; Jejunum; Male; Middle Aged; Neomycin; Nutrition Disorders; Protein Deficiency; Stomach; Tetracycline; Vitamin B 12; Xylose | 1970 |
[Dynamics of the distribution of rifocin in patients with chronic tonsillitis at different methods of administration].
Topics: Adolescent; Adult; Aerosols; Ampicillin; Anti-Bacterial Agents; Bacteria; Child; Chronic Disease; Depression, Chemical; Erythromycin; Erythromycin Ethylsuccinate; Humans; Injections, Intramuscular; Iontophoresis; Methacycline; Methicillin; Middle Aged; Neomycin; Oleandomycin; Oxacillin; Palatine Tonsil; Penicillin Resistance; Rifampin; Saliva; Staphylococcus; Streptococcus; Tetracycline; Time Factors; Tonsillitis | 1970 |
[Use of antibiotics in surgery].
Topics: Abdomen; Anti-Bacterial Agents; Appendicitis; Chloramphenicol; Chronic Disease; Erythromycin; Erythromycin Ethylsuccinate; Escherichia coli; Exudates and Transudates; Herniorrhaphy; Humans; Neomycin; Penicillin Resistance; Penicillins; Pneumonia; Postoperative Complications; Staphylococcal Infections; Staphylococcus; Streptomycin; Surgical Wound Infection; Tetracycline | 1971 |
[Instillation treatment of the infected bladder with special reference to its absorption capacity].
Topics: Chronic Disease; Cystitis; Drug Synergism; Humans; Neomycin; Specimen Handling; Sulfonamides | 1972 |
Familial benign chronic pemphigus. The role of trauma including contact sensitivity.
Topics: Adult; Axilla; Chronic Disease; Dermatitis, Contact; Drug Hypersensitivity; Female; Humans; Humidity; Neck; Neomycin; Nitrogen; Occlusive Dressings; Pemphigus; Skin | 1971 |
Lactulose in the treatment of acute and chronic hepatic encephalopathy.
Topics: Acute Disease; Aged; Brain Diseases; Chronic Disease; Disaccharides; Fructose; Humans; Liver Diseases; Male; Middle Aged; Neomycin | 1971 |
Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature.
Topics: Aged; Ammonia; Brain Diseases; Cathartics; Chronic Disease; Colon; Diarrhea; Dietary Proteins; Disaccharides; Electroencephalography; Feces; Female; Hepatic Encephalopathy; Humans; Lactobacillus; Liver Cirrhosis; Male; Middle Aged; Neomycin; Portal System; Urease | 1971 |
[Use of Dontisolon in the conservative treatment of progressive periodontitis].
Topics: Adolescent; Adult; Chronic Disease; Chymotrypsin; Drug Combinations; Female; Humans; Male; Middle Aged; Neomycin; Periodontitis; Prednisolone; Subgingival Curettage; Trypsin | 1971 |
[Study of the effect of some antibiotics in combination with the new sulfanilamide preparation sulfapyridazine in experimental chronic staphylococcal infection].
Topics: Animals; Anti-Bacterial Agents; Chlortetracycline; Chronic Disease; Drug Synergism; Erythromycin; Mice; Neomycin; Penicillin G; Penicillin Resistance; Pyridazines; Staphylococcal Infections; Staphylococcus; Sulfanilamides | 1966 |
Vernal kerato-conjunctivitis and its management.
Topics: Acetylcysteine; Chronic Disease; Cornea; Corneal Ulcer; Drug Hypersensitivity; Glucocorticoids; Humans; Hypersensitivity; Keratoconjunctivitis; Neomycin | 1971 |
[The treatment of patients with chronic prostatitis].
Topics: Anti-Bacterial Agents; Chronic Disease; Humans; Hydrocortisone; Male; Neomycin; Penicillins; Prostatitis | 1969 |
Familial benign chronic pemphigus of perianal skin.
Topics: Adult; Anus Diseases; Chronic Disease; Humans; Male; Neomycin; Pemphigus; Triamcinolone | 1971 |
[Experience with Dorithricin-ear drops].
Topics: Anti-Bacterial Agents; Chronic Disease; Dosage Forms; Ear Canal; Ear Diseases; Eustachian Tube; Humans; Neomycin; Otitis Externa; Otitis Media; Tympanic Membrane; Tyrothricin | 1967 |
[Treatment of chronic porto-systemic encephalopathy with lactulose].
Topics: Brain Diseases; Chronic Disease; Disaccharides; Humans; Liver Cirrhosis; Neomycin; Portal System; Vascular Diseases | 1969 |
Long-term treatment of portal-systemic encephalopathy with lactulose.
Topics: Adult; Brain Diseases; Carbohydrates; Chronic Disease; Diet Therapy; Dietary Proteins; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Methods; Middle Aged; Neomycin; Portal System | 1969 |